Last $414.13 USD
Change Today +1.34 / 0.32%
Volume 1.5M
As of 5:20 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George A. Scangos Ph.D.

Chief Executive Officer and Director, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 132 board members in 8 different organizations across 11 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. George A. Scangos, Ph.D. has been the Chief Executive Officer at Biogen Idec Inc and Biogen Idec Ltd since July 2010. Dr. Scangos served as the President and Chief Executive Officer of Exelixis, Inc., a holding company of X-ceptor Therapeutics Inc. from October 1996 to July 2010. He served as the President of Biotechnology of Bayer Corporation from September 1993 to October 1996 and was responsible for 1,100 employees in research and development, business development, ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-679-2000
Fax: --

Board Members Memberships*

Vice Chairman
Former Non-Executive Director and Member of Remuneration Committee
Former Director
Former Chairman and Member of Compensation Committee
Chief Executive Officer and Director
Chief Executive Officer and Director
Director, Member of Compensation Committee and Member of Nominating/Corporate Governance Committee


Cornell University
University Of Massachusetts

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,498,462

Stock Options*

Restricted Stock Awards$9,195,217
All Other Compensation$671,511

Total Compensation*

Total Annual Cash Compensation$5,730,453
Total Short Term Compensation$1,498,462
Other Long Term Compensation$9,866,728
Total Calculated Compensation$15,015,147
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $414.13 USD +1.34


Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at